Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
China flag China · Delayed Price · Currency is CNY
40.37
-0.46 (-1.13%)
Nov 6, 2026, 3:00 PM CST

SHA:600211 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
991.91937.931,051800.91369.84208.94
Depreciation & Amortization
78.3478.3475.268.0569.2481.45
Other Amortization
2.062.060.641.011.550.68
Loss (Gain) From Sale of Assets
-0.11-0.11-1.96-0.340.230.04
Asset Writedown & Restructuring Costs
0.030.030.07190.38218.62458.19
Loss (Gain) From Sale of Investments
-4.15-4.153.88170.097.14-146.47
Provision & Write-off of Bad Debts
-0.4-0.40.60.04-0.51-1.39
Other Operating Activities
24.36-14.87-12.63-5.6881.9415.93
Change in Accounts Receivable
-195.42-195.4298.83-237.8922.82-317.1
Change in Inventory
-43.3-43.3-22.56-16.56-18.87-67.2
Change in Accounts Payable
225.41225.41-163.73147.438.73164.85
Change in Other Net Operating Assets
0.370.372.021.8752.43-1.62
Operating Cash Flow
1,0981,005994.791,063837.38366.53
Operating Cash Flow Growth
14.30%1.00%-6.45%26.99%128.46%-14.39%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-22.14-15.96-37.6-21.69-101.96-425.58
Sale of Property, Plant & Equipment
0.350.342.780.540.1116.78
Cash Acquisitions
162.39162.48----
Investment in Securities
-179.46-757.91367.91-829.46-471.69-334.97
Other Investing Activities
-128.1121.9721.3918.7212.32.97
Investing Cash Flow
-166.96-589.07354.49-831.88-561.25-740.8

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-980.11533.5699.51485.73-
Long-Term Debt Issued
-----576.54
Total Debt Issued
1,549980.11533.5699.51485.73576.54
Short-Term Debt Repaid
--502.19-760.97-685.73-534.27-
Long-Term Debt Repaid
--1.03-0.93-1.65-3.56-56.08
Lease Payments
-1.03-1.03-0.93-1.65-3.56-3.4
Total Debt Repaid
-1,260-503.22-761.9-687.39-537.82-56.08
Net Debt Issued (Repaid)
288.67476.89-228.412.13-52.09520.46
Common Dividends Paid
-660.15-613.53-504.05-494.47-98.18-132.49
Other Financing Activities
-15014.02-0.54-1.344.9-11.3
Financing Cash Flow
-521.47-122.62-732.99-483.69-145.37376.67

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-77.83-22.457.447.0440.11-14.42
Net Cash Flow
331.69270.6623.72-245.11170.87-12.02

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,076988.79957.191,042735.41-59.05
Free Cash Flow Growth
16.19%3.30%-8.12%41.65%--
Free Cash Flow Margin
35.06%33.16%34.10%33.24%28.79%-2.76%
Free Cash Flow Per Share
3.343.072.973.232.28-0.18
Levered Free Cash Flow
645.96697.85483.26585.86456.08-60.38
Unlevered Free Cash Flow
675.59705.72489.19593.11465.06-57.68
Free Cash Flow After Leases
1,075987.76956.261,040731.86-62.45

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
87.79392.38500.59443.23272.41274.84
Change in Working Capital
5.925.92-122.3-161.0589.34-250.83